Serveur d'exploration Tocilizumab - Checkpoint (Istex)

Index « Teeft.i » - entrée « Median »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Medial tibiofemoral < Median < Median baseline  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 138.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000340 (2013) Muriel Elhai [France] ; Marine Meunier [France] ; Marco Matucci-Cerinic [Italie] ; Britta Maurer [Suisse] ; Gabriela Riemekasten [Allemagne] ; Tifenn Leturcq [France] ; Raffaele Pellerito [Italie] ; Carlos Alberto Von Mühlen [Brésil] ; Alessandra Vacca [Italie] ; Paolo Airo [Italie] ; Francesca Bartoli [Italie] ; Ginevra Fiori [Italie] ; Maria Bokarewa [Suède] ; Valeria Riccieri [Italie] ; Mike Becker [Allemagne] ; Jérôme Avouac [France] ; Ulf Müller-Ladner [Allemagne] ; Oliver Distler [Suisse] ; Yannick Allanore [France]Outcomes of patients with systemic sclerosis-associated polyarthritis and myopathy treated with tocilizumab or abatacept: a EUSTAR observational study
000346 (2013) C. Malattia [Italie] ; A. Consolaro [Italie] ; S. Pederzoli [Italie] ; A. Madeo [Italie] ; A. Pistorio [Italie] ; M. Mazzoni [Italie] ; C. Mattiuz [Italie] ; Gm Magnano [Italie] ; S. Viola [Italie] ; A. Buoncompagni [Italie] ; E. Palmisani [Italie] ; R. Hasija [Italie] ; N. Ruperto [Italie] ; A. Ravelli [Italie] ; A. Martini [Italie]MRI versus conventional measures of disease activity and structural damage in evaluating treatment efficacy in juvenile idiopathic arthritis
000358 (2013) Tsutomu Takeuchi [Japon] ; Masayoshi Harigai [Japon] ; Yoshiya Tanaka [Japon] ; Hisashi Yamanaka [Japon] ; Naoki Ishiguro [Japon] ; Kazuhiko Yamamoto [Japon] ; Nobuyuki Miyasaka [Japon] ; Takao Koike [Japon] ; Minoru Kanazawa [Japon] ; Takuya Oba [Japon] ; Toru Yoshinari [Japon] ; Daniel Baker [États-Unis]Golimumab monotherapy in Japanese patients with active rheumatoid arthritis despite prior treatment with disease-modifying antirheumatic drugs: results of the phase 2/3, multicentre, randomised, double-blind, placebo-controlled GO-MONO study through 24 weeks
000361 (2013) Marieke H. Otten [Pays-Bas] ; Femke H M. Prince [Pays-Bas] ; Janneke Anink [Pays-Bas] ; Rebecca Ten Cate [Pays-Bas] ; Esther P A H. Hoppenreijs [Pays-Bas] ; Wineke Armbrust [Pays-Bas] ; Yvonne Koopman-Keemink [Pays-Bas] ; Philomine A. Van Pelt [Pays-Bas] ; Sylvia Kamphuis [Pays-Bas] ; Simone L. Gorter [Pays-Bas] ; Koert M. Dolman [Pays-Bas] ; Joost F. Swart [Pays-Bas] ; J Merlijn Van Den Berg [Pays-Bas] ; Nico M. Wulffraat [Pays-Bas] ; Marion A J. Van Rossum [Pays-Bas] ; Lisette W A. Van Suijlekom-Smit [Pays-Bas]Effectiveness and safety of a second and third biological agent after failing etanercept in juvenile idiopathic arthritis: results from the Dutch National ABC Register
000366 (2013) Bente Glintborg [Danemark] ; Mikkel Stergaard [Danemark] ; Niels Steen Krogh [Danemark] ; Ulrik Tarp [Danemark] ; Natalia Manilo [Danemark] ; Anne Gitte Rasmussen Loft [Danemark] ; Annette Hansen [Danemark] ; Annette Schlemmer [Danemark] ; Victoria Fana [Danemark] ; Hanne M. Lindegaard [Danemark] ; Henrik Nordin [Danemark] ; Claus Rasmussen [Danemark] ; Leif Ejstrup [Danemark] ; Dorte Vendelbo Jensen [Danemark] ; Peter Mosborg Petersen [Danemark] ; Merete Lund Hetland [Danemark]Clinical response, drug survival and predictors thereof in 432 ankylosing spondylitis patients after switching tumour necrosis factor α inhibitor therapy: results from the Danish nationwide DANBIO registry
000413 (2013) M. Hoepfner ; T. Witte ; N. Pursche ; F. Moosig [Allemagne] ; W. Gross [Allemagne] ; R. E. Schmidt ; N. T. BaerleckenTHU0489 Antibodies Binding to DRP-4 and Macropain Subunit C2 as a Potential Marker of AOSD
000414 (2013) Y. Takakuwa ; S. Ooka ; H. Ito [Japon] ; T. Kiyokawa [Japon] ; H. Nakano ; M. Hiida [Japon] ; H. Yamada ; S. OzakiTHU0488 Efficacy and Safety of Biologic Agents for the Treatment of Refractory Adult Still’s Disease
000415 (2013) A. Mesut Onat ; Y. Pehlivan ; T. Demir ; D. Sinan Kaplan ; M. Orkmez ; I. Halil Turkebeyler [Turquie] ; S. Taysi ; B. KisacikTHU0487 Palosuran Treatment, Effective as Bosentan in the Treatment of Pulmonary Arterial Hypertension (PAH) Model
000437 (2013) A. Meyer [France] ; A. Theulin ; E. Chatelus ; C. Sordet ; R.-M. Javier ; B. Geny [France] ; J.-E. Gottenberg ; J. SibiliaTHU0412 Reactive hyperemia index (RHI) is associated with macrovascular disease and lung disease in systemic sclerosis
000438 (2013) A. M. Istrate [Espagne] ; E. De Miguel [Espagne] ; I. Felea [Espagne] ; M. Caracuel Ruíz [Espagne] ; E. Collantes-Estevéz [Espagne]THU0411 Utility of ultrasound scores in assessment enthesitis on anti-TNF therapy of spondyloarthritis patients
000439 (2013) Y. Takakuwa ; H. Yamada ; H. Ito ; S. Ooka ; Y. Yamasaki ; H. Nakano ; M. Hiida ; Y. Kurihara [Japon] ; S. OzakiTHU0410 Characterisation of interstitial lung disease associated with adult still’s disease
000457 (2013) H. J. Lachmann [Royaume-Uni] ; J. D. Gillmore [Royaume-Uni] ; A. D. Wechalekar [Royaume-Uni] ; S. D. Gibbs [Royaume-Uni] ; J. H. Pinney [Royaume-Uni] ; D. M. Rowczenio [Royaume-Uni] ; H. Trojer [Royaume-Uni] ; T. Lane [Royaume-Uni] ; C. P. Venner [Royaume-Uni] ; S. M. Banypersad [Royaume-Uni] ; J. A. Gilbertson [Royaume-Uni] ; F. T. Hunt [Royaume-Uni] ; D. Gopaul [Royaume-Uni] ; D. F. Hutt [Royaume-Uni] ; N. Wassef [Royaume-Uni] ; M. B. Pepys [Royaume-Uni] ; P. N. Hawkins [Royaume-Uni]THU0379 A 20 year single centre experience of aa amyloidosis demonstrating changes in its epidemiology
000470 (2013) S. Vastert ; W. De Jager [Pays-Bas] ; B. J. Noordman [Pays-Bas] ; D. Holzinger [Allemagne] ; W. Kuis ; B. Prakken ; N. WulffraatTHU0333 Effectiveness and long-term follow up of recombinant IL-1RA as first line therapy in newly onset juvenile idiopathic arthritis
000471 (2013) R. Carrasco [Royaume-Uni] ; L. R. Wedderburn [Royaume-Uni] ; H. E. Foster ; E. Baildam ; J. Gardner-Medwin [Royaume-Uni] ; A. Chieng [Royaume-Uni] ; J. Davidson [Royaume-Uni] ; W. Thomson [Royaume-Uni] ; K. Hyrich [Royaume-Uni]THU0332 Predictors of poor growth in children with early juvenile idiopathic arthritis: Results from the childhood arthritis prospective study (CAPS)
000472 (2013) R. Campanilho-Marques [Portugal] ; F. Ramos [Portugal] ; J. Romeu [Portugal] ; J. A. Pereira Da Silva [Portugal]THU0331 Management of osteoporosis in children: Experience from a pediatric rheumatology center
000477 (2013) G. Horneff ; K. Minden [Allemagne] ; I. Foeldvari [Allemagne]THU0310 Performance of the juvenile arthritis disease activity score JADAS compared to the acr pediatric measures of response in 1470 juvenile idiopathic arthritis patients
000481 (2013) F. Falcini ; V. Denaro ; F. Cuoco ; G. Martini ; S. Cappelli ; A. Petaccia ; F. Corona ; G. Carnesecchi ; F. La Torre ; M. Matucci Cerinic ; D. Rigante [Italie]THU0306 Predictors of outcome in a cohort of italian children/adolescents with primary raynaud’s phenomenon: A multicenter study
000482 (2013) T. Hallinen [Finlande] ; E. J. Soini [Finlande] ; A. Diamantopoulos [Royaume-Uni] ; F. Dejonckheere [Suisse] ; V. Vihervaara ; A. Hautala ; K. Aalto [Finlande]THU0305 Cost-utility of tocilizumab in the treatment of systemic juvenile idiopathic arthritis in finland
000502 (2013) H. H. Nordal ; H. B. Hammer ; M. K. Fagerhol [Norvège] ; A. K. Halse [Norvège] ; R. Jonsson ; J. G. Brun [Norvège]THU0158 The Inflammatory Marker S100A12 is Highly Associated with a Comprehensive 78-Joints Ultrasonographic Synovitis Score in Patients with Rheumatoid Arthritis Treated with Adalimumab
000503 (2013) H. B. Hammer [Norvège] ; T. K. Kvien [Norvège]THU0157 Comprehensive Ultrasound Assessments are Closely Related to Clinical Evaluations of Inflammatory Activity but not with the Patient Developed Raid Questionnaire in RA Patients on Biologic Treatment
000504 (2013) G. Imametdinova ; E. Igolkina ; N. Chichasova ; E. Nasonov [Russie] ; S. Glukhova [Russie]THU0156 The Evaluation of Joint Damage Progression in Patients with Rheumatoid Arthritis with Long-Term and Short-Term Remission

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Istex/Checkpoint
HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Checkpoint/Teeft.i -k "Median" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Checkpoint/Teeft.i  \
                -Sk "Median" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Istex
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Teeft.i
   |clé=    Median
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021